Summary The incidence of nodal metastasis in early gastric carcinoma (EGC) is 10-20%. However, the optimal nodal dissection for early gastric carcinoma has not been established. A retrospective study was conducted in 392 consecutive patients who underwent potentially curative distal gastrectomy for EGC between 1962 and 1990. Of these 295 patients treated after September 1972 were prospectively entered into an extensive lymphadenectomy protocol. These patients were compared with 97 patients with simple gastrectomy in respect of the causes of death after surgery and the 10 year disease-specific survival rate. The incidence of nodal metastasis in early gastric carcinoma patients was 13.0%. Operative mortality from extensive lymphadenectomy was almost the same as from simple gastrectomy (2.0% and 2.1% respectively). Extensive al., 1987; Ohta et al., 1987; Marczel et al., 1988; Lehnert et al., 1989; Percivale et al., 1989; Farley et al., 1992; Maehara et al., 1993) . Nevertheless, the optimal extent of lymph node dissection for EGC has not been well established. Japanese surgeons normally perform extensive lymphadenectomy for EGC because a certain proportion of these patients have lymph nodal involvement and carcinoma recurrence is not rare. In contrast, most surgeons in Western countries do not use aggressive surgery (Cuschieri, 1986; Heberer et al., 1988; Irvin and Bridger, 1988; Heesakkers et al., 1994) , perhaps because of uncertainty regarding improvement in the survival rate and the high operative risk associated with extensive lymph node dissection (Dent et al., 1988; Heberer et al., 1988; Irvin and Bridger, 1988) .
Although its incidence is decreasing, gastric carcinoma still ranks as the second leading cause of cancer death in the world. In order to improve the outcome in gastric carcinoma, it is important that it be detected at an early stage and treated adequately. Early gastric carcinoma (EGC) is defined as carcinoma with limited invasion into the gastric mucosa or submucosa with or without metastasis. EGC has a 10-20% incidence of nodal metastasis (Maruyama et al., 1987; Ohta et al., 1987; Marczel et al., 1988; Lehnert et al., 1989; Percivale et al., 1989; Farley et al., 1992; Maehara et al., 1993) . Nevertheless, the optimal extent of lymph node dissection for EGC has not been well established. Japanese surgeons normally perform extensive lymphadenectomy for EGC because a certain proportion of these patients have lymph nodal involvement and carcinoma recurrence is not rare. In contrast, most surgeons in Western countries do not use aggressive surgery (Cuschieri, 1986; Heberer et al., 1988; Irvin and Bridger, 1988; Heesakkers et al., 1994) , perhaps because of uncertainty regarding improvement in the survival rate and the high operative risk associated with extensive lymph node dissection (Dent et al., 1988; Heberer et al., 1988; Irvin and Bridger, 1988) .
To evaluate the therapeutic value of extensive lymphadenectomy in EGC, we analysed retrospectively the causes of death after surgery and compared the 10 year disease-specific survival rate in patients who had received extensive lymphadenectomy with patients who had received simple gastric resection.
Patients and methods

Patients
Between August 1962 and May 1990 , 2088 went gastric resection at Surgery II, University Hospital, School of Medicine, Kanazawa University. A total of 503 (24.0%) of these patients had EGC. Seventy-one patients who received a total or proximal gastrectomy for EGC located in the upper third of the stomach and 35 patients with multifocal gastric carcinoma were excluded from this study. Five patients who underwent non-curative procedures, such as those with hepatic metastasis, Virchow's nodal involvement, and inadequate local resection were also excluded. Thus, the present study included 392 patients with EGC who underwent potentially curative distal gastric resection. Of these 392 patients, 295 patients were treated by extensive lymph nodes dissection (ELND) and 97 patients were treated by distal gastrectomy with limited lymph node dissection (LLND) . ELND was performed beginning in September 1972. The LLND group consisted of 68 patients before September 1972 and 29 patients after. Each surgical procedure is outlined below. The subjects were followed up, and the effect of lymph node dissection on their 10 year disease-specific survival was evaluated. The operative and pathological findings were assessed according to the guidelines of the Japanese Research Society for Gastric Cancer (1981) . The median age of the patients at the time of operation was 59 years, with a range of 18-84 years. There were 271 males (69%) and 121 females (31%).
Surgery
The ELND gastrectomy was performed as follows: the entire greater omentum, superior leaf of the mesocolon, pancreatic capsule and lesser omentum were removed en bloc with the cancerous distal portion of the stomach. Each of the supplying gastric arteries was ligated and divided at its origin, and the group 1 lymph nodes (nl), namely those along the lesser and greater curvatures, as well as the supra-and infra-pyloric lymph nodes, were completely dissected. In addition, the group 2 lymph nodes (n2) located at the right side of the cardia, and along the left gastric, common hepatic and coeliac arteries were also dissected. In some patients, additional group 3 lymph node (n3) dissection was performed at the hepatoduodenal ligamentum, retropancreatic area and along the superior mesenteric vein. This nodal dissection is similar to R2/R3 in the Japanese rules.
The LLND gastrectomy was conservatively performed in the same manner as distal gastrectomy for ulcer disease; the gastrocolic ligamentum was divided between the stomach and the transverse colon. The right and left gastroepiploic arteries and the right gastric artery were ligated separately and divided near the gastric resection margin. The left gastric artery was ligated and divided at a distance from its origin.
This procedure included removal of only the perigastric lymph nodes along the lesser and greater curvatures to the extent required for gastric resection. This procedure is similar to Ro/Rl in the Japanese rules.
The reconstruction was made using Billroth I or II anastomosis.
Pathological examination
The resected stomach was opened along the greater curvature and macroscopically evaluated intrasurgically. The macroscopic appearance of the tumour was identified and its greatest diameter measured. After surgery, each lymph node was dissected by the attending surgeon, and classified according to the lymph node designations used in the Japanese Gastric Cancer Study. Histologically, the tumour was evaluated either as differentiated, including papillary, well-differentiated or moderately differentiated tubular or as undifferentiated, including poorly differentiated, mucinous, and signet ring cell type.
Analysis
The clinical and pathological data for the patients were entered into a personal computer (PC-9801 VX, NEC, Tokyo) using the Beccel Mark-II software system (Beccel, Tokyo). For all patients, follow-up information including the cause of death was obtained using a yearly routine examination at our department, or questionnaire or telephone contact with the patient, local doctor or family. The patients were followed up until death or until December, 1994. The followup rate was 99.0% (388/392). The average duration of follow-up was 14 years, with a range of 4-27 years. The survival rates were calculated by use of Kaplan-Meier estimate (Kaplan and Meier, 1958) (Peto and Pike, 1973) was used.
Multivariate analysis of independent prognostic factors shown to be prognostically significant, with a P-value near 0.05 in the univariate analysis, was performed using the Cox proportional hazards model (Cox, 1972) . Operative mortality was defined as in-hospital mortality. All other statistics were performed using the chi-square test with the Fisher's exact test for categorical variables, and the Wilcoxon signed rank test for continuous variables. A difference was considered to be significant when the P-value was less than 0.05. Table I shows the overall patient characteristics of patients in the ELND and LLND groups. The demographics and historical risk factors in the patients treated with ELND were similar to those in the patients treated with LLND with the exceptions of number of dissected nodes and number of nodes positive.
Results
Clinicopathological characteristics
Nodal metastasis Nodal metastasis was found in 51 patients (13.0%). The incidence of nodal metastasis was 12.2% in the ELND group and 15.5% in the LLND group. This difference was not significant (P = 0.51). The number of dissected lymph nodes in the ELND group was significantly larger than that of the LLND group [medians (range): 37 (8-104) vs 15 (6-29); P < 0.0001] and the average number of metastatic nodes was also significantly increased in the former [median (range): 2.5 (1-26) vs 1 (1-6); P<0.005). Of the 295 patients who underwent the ELND procedure, lymph nodal metastasis was limited to nl(+) in 25 patients (8.5%), extended to n2(+) in nine (3.1%), and even to n3(+) in two (0.6%).
Cause of death
As of December 1994, 277 patients were alive, 111 had died and the remaining four patients had been lost to follow-up. ELND group (87.5% and 99.4%; P<0.001) and in the LLND group (55.6% and 94.6%; P<0.0001).
As shown in Figure 1 , the 10 year survival rate in the ELND group was 97.9%, while in the LLND group it was 88.1% (P<0.005). The 10 year survival rate in patients with nodal metastasis in the ELND group was 87.5%, significantly higher than the 55.6% in those with nodal metastasis in the LLND group (P = 0.018) (Figure 2 ). On the other hand, no significant difference was found between the ELND and LLND group patients without nodal metastasis in 10 year survival rate (99.4% and 96.7% respectively; P = 0.12) (Figure 3) . The 10 year survival rate was 82.0% in the group with two or more positive nodes and 78.3% in that with one positive node; this difference was not significant (P = 0.8).
When the patients were classified according to the depth of carcinoma invasion, the 10 year survival rate in those in the ELND group with submucosal carcinoma was significantly higher than in those in the LLND group with submucosal carcinoma (96.3% vs 82.2%; P = 0.013). On the other hand, no difference was found between the ELND and the LLND groups in the 10 year survival rates of patients with mucosal carcinoma (99.1% and 95.2% respectively; P = 0.3) ( Figure  4 ).
Survival
The overall 5 and 10 year survival rates in the EGC patients was 97.7% and 95.2% respectively.
The 10 year survival rate in the patients with nodal metastasis was 77.4%, whereas in those without metastasis it was 98.0%. This difference is significant (P<0.0001). There was also a significant difference in the 10 year survival rate between patients with and without nodal metastasis in the In the present study, 392 patients with EGC were evaluated and followed up 10 years after surgery. The reason why we followed for such a long time is that cancer death occurs often 5-10 years after surgery (Itoh et al., 1989; Furusawa et al., 1991; Moreaux and Bougaran, 1993; Sano et al., 1993) . Indeed, the present study revealed that only 43% of the recurred patients died 5 years after surgery. The 10 year survival rate of patients wtih ELND gastrectomy was significantly higher than that of patients with LLND gastrectomy. This difference was observed only in patients with nodal metastasis, and not in those without metastasis. Thus ELND gives a survival benefit to node-positive EGC patients.
When more extensive lymph node dissection is performed, the capacity to stage patients by nodal status is enhanced. The impact of screening programmes on clinical presentation is a fact which has been reported in other cancers as well. Stage shifting must be considered in interpreting the present results. We conducted a thorough pathological examination of all lymph nodes in the resected specimens in the two groups, and found that in the extensive lymphadenectomy group, not only was the total number of dissected nodes increased, but also the number of metastatic nodes was increased by the ELND procedure. However, no increment in the incidence of patients with positive nodes in the ELND group was observed compared with the LLND group. The extended procedure did not result in any significant stage shifting in these patients.
There are some reports that EGC patients with nodal metastasis have a poorer prognosis than those with cancernegative nodes (Habu et al., 1986; Marczell et al., 1988; Inoue et al., 1991; Lawrence and Shiu, 1991; Santoro et al., 1991; Guadagni et al., 1993; Pinto et al., 1994) . This aspect is supported by our findings not only for the LLND group but also for the ELND group. Although ELND brought about a significantly increased number of positive lymph nodes, the survival rate of patients with nodal metastasis in the ELND group was significantly increased from that in the LLND group. These observations suggest that most of the EGC When the lymph nodes are enlarged, metastasis can generally be easily diagnosed by gross examination. However, when they are not enlarged, surgeons cannot easily determine intraoperatively whether metastatic foci are present or not. The nodal status of EGC are generally of the latter type (Sano et al., 1994) . Although frozen lymph node sections certainly provide reliable information, the ability to examine a large number of lymph nodes is limited. Thus, the nodal status cannot be accurately diagnosed before the postoperative pathological examination.
Some reports indicate that the survival rate differs according to whether the depth of invasion is mucosal or submucosal (Gentsch et al., 1981; Takagi et al., 1987; Craanen et al., 1991; Lawrence and Shiu, 1991; Inoue et al., 1991; Guadagni et al., 1993; Moreaux and Bougaran, 1993) . It is well established that, as the depth of gastric carcinoma invasion into the gastric wall increases, the frequency and the degree of nodal metastasis also increases. Lymph nodal metastasis is present in 1.8-4.8% of EGC patients with mucosal invasion, but in 16.7-23.8% of those with submucosal invasion (Habu et al., 1986; Korenaga et al., 1986; Ohta et al., 1987; Iriyama et al., 1989; Sowa et al., 1989; Inoue et al., 1991; Moreaux and Bougaran, 1993) . Thus, the local invasiveness of EGC may be correlated with the survival rate (Lawrence and Shiu, 1991) . However, in the present study, the survival of patients with submucosal invasion who underwent the ELND procedure was significantly higher than those who underwent the LLND procedure, and almost similar to that of patients with mucosal invasion who underwent either procedure. These findings indicate that the ELND procedure should be used in patients with submucosal carcinoma.
The reported incidence of nodal metastasis was 12.9% among 791 patients with EGC treated at the Cancer Institute Hospital, Tokyo (Takagi et al., 1987) ; 8.8% in nl(+), 3.2% in n2(+) and 0.5% in n3(+). Our study demonstrated almost the same incidence of metastasis, 8.5% in nl( +), 3.1% in n2(+) and 0.6% in n3(+). When dealing with small number of patients, the low incidence in either n2( +) or n3(+) may be insignificant, a fact that could mask the superiority of ELND for EGC with nodal metastasis.
In contrast, it is debatable whether aggressive surgery should be considered for mucosal carcinomas. Lymph node metastases do occur in patients once the basement membrane has been breached since there are lymphatics within the deeper layers of the mucosa, above the submucosa. Korenaga et al. (1986) recommended lymph node dissection even in patients with mucosal carcinoma, because they found meta-0 1523 stases to distant lymph nodes in three of 568 patients with mucosal EGC. Lawrence and Shiu (1991) also emphasised that extended lymphadenectomy should be used in all patients with EGC, even in those in whom mucosal invasion is identified. However, in our study, the survival rate for patients with mucosal carcinoma treated using the ELND procedure was only slightly different from those treated using the LLND procedure. Numerous clinicopathological studies have demonstrated that the frequency of nodal metastasis in EGC with mucosal invasion is less than 5%. The degree of nodal invasion is almost always limited to nl(+), and in less than 1% of the cases with n2( +) (Habu et al., 1986; Korenaga et al., 1986) . EGC patients with n2( +) would have been cured only by the ELND procedure but this would have resulted in a comparatively small improvement in the survival rate. This relatively small survival benefit must be considered against the increased operative risks of extended lymphadenectomy. Although the operative mortality rate of 2% associated with the ELND procedure seems to be acceptable, some researchers have reported that more aggressive surgery may be related to higher operative morbidity and mortality (Diggory and Cuschieri, 1985; Heberer et al., 1988; Dent et al., 1988) . In addition, the ELND procedure presents the disadvantage of longer operation time and greater blood loss, although these factors were not associated with any increase in the mortality rate (de Aretxabala et al., 1987; Smith et al., 1991; Pacelli et al., 1993) . Therefore, the most appropriate treatment in an individual patient with EGC in whom invasion is limited to the mucosal layer must be determined after full consideration of all the risks and benefits. Recently, in some selected cases of gastric mucosal carcinoma, Japanese surgeons attempted cautiously to perform endoscopic mucosal resection or limited surgery such as local resection, segmental resection, pylorus-preserving gastrectomy and RI gastrectomy. Certainly, such limited procedures improved patients' quality of life, but the value of limited procedures should be estimated inclusive of the risk of carcinoma recurrence in future.
The distinction of mucosal carcinoma from submucosal carcinoma is important in limited procedures. Radiographic or endoscopic diagnosis is often inaccurate. It is not rare for a tumour that has been grossly diagnosed as mucosal carcinoma to infiltrate into the submucosal layer or deeper. We know for certain that the protruded type EGC less than 2.0 cm in diameter is limited to the mucosa and that it lacks nodal metastasis (Kitaoka et al., 1984; Korenaga et al., 1986; Ohta et al., 1987; Iriyama et al., 1989) . In addition, if a tumour shows a depressed differentiated adenocarcinoma less than 1.0cm in diameter, then it has little chance of nodal metastasis (Takekoshi et al., 1994) . A limited procedure can be indicated in these cases only. Otherwise, endoscopic ultrasonography can be a useful tool for deciding the indication of limited procedures. Yoshino et al. (1987) reported that the rate of correct diagnosis in endoscopic ultrasonography was 83.3% in mucosal carcinoma and 71.4% in carcinoma with submucosal invasion, while the accurate rate of radiographic examination was 73.0% and 64.7% respectively. The accuracy of endoscopic ultrasonography in our own experience was 88.9% in mucosal carcinoma and 62.5% in submucosal carcinoma. Therefore the accuracy rate of endoscopic ultrasonography is higher than that of radiographic examination, but it is not high enough to be used to indicate a limited procedure. Further development of instruments for endoscopic ultrasonography may facilitate more accurate distinction between these two depths of carcinoma invasion.
In conclusion, our retrospective findings suggest that aggressive lymph node dissection, in spite of the prolonged operation time and increased loss of blood, increases the survival rate of EGC patients with nodal metastasis. On the other hand, EGC without nodal involvement does not require any aggressive nodal dissection. We need a search for a new diagnostic technique to differentiate EGC patients regarding the presence or absence of nodal metastasis preoperatively or perioperatively.
